Literature DB >> 2540091

Independence of neutrophil respiratory burst oxidant generation from the early cytosolic calcium response after stimulation with unopsonized Candida albicans hyphae.

D R Wysong1, C A Lyman, R D Diamond.   

Abstract

We previously noted differences between neutrophil responses to unopsonized Candida albicans hyphae and responses to other particulate stimuli such as opsonized hyphae or zymosan; these differences include delayed rises in cytosolic calcium [( Ca2+]i), 1,4,5-inositol trisphosphate, and superoxide release and the total absence of early membrane depolarization. Respiratory burst stimulation is required for killing of C. albicans hyphae. Since an early rise in [Ca2+]i may act as a second messenger for burst activation by most agonists, we chelated (Ca2+)i and extracellular Ca2+ [( Ca2+)e] to compare requirements for superoxide responses to hyphae and other stimuli. Intracellular chelation, which ablated early [Ca2+]i rises, eliminated the fMet-Leu-Phe-induced respiratory burst and profoundly reduced that response to opsonized zymosan (by 96.7%), but chelation of both (Ca2+)i and (Ca2+)e only partially inhibited responses to opsonized and unopsonized hyphae (60.5 and 23.3%, respectively; the latter exceeded absolute responses evoked by opsonized zymosan, a 12-fold-more-potent stimulus for unchelated cells). Simultaneous (Ca2+)i and (Ca2+)e chelation further decreased superoxide responses to opsonized zymosan and hyphae (99.4 and 90.4%, respectively) but not to unopsonized hyphae (26.7% inhibition). Though both ingestible (zymosan) and uningestible (hyphae) opsonized particulate stimuli elicited reduced but significant respiratory bursts without early [Ca2+]i rises, the greater superoxide responses and sensitivity to chelation with opsonized zymosan suggest important differences in initiation and/or regulation of responses to these particulate stimuli. In contrast, the respiratory burst elicited by unopsonized hyphae appeared largely Ca2+ independent. If different events mediate neutrophil activation by opsonized and unopsonized hyphae, candidacidal activity in vivo may vary under divergent conditions with specific localized sites of infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540091      PMCID: PMC313305          DOI: 10.1128/iai.57.5.1499-1505.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Comparative quantitation of immunoglobulin G (IgG) in cerebrospinal fluid and serum of children.

Authors:  D Harms
Journal:  Eur Neurol       Date:  1975       Impact factor: 1.710

2.  Ion movement across leukocyte plasma membrane and excitation of their metabolism.

Authors:  D Romeo; G Zabucchi; N Miani; F Rossi
Journal:  Nature       Date:  1975-02-13       Impact factor: 49.962

3.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Fluoride-mediated activation of the respiratory burst in human neutrophils. A reversible process.

Authors:  J T Curnutte; B M Babior; M L Karnovsky
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

6.  Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro.

Authors:  R D Diamond; R A Clark; C C Haudenschild
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

7.  Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro.

Authors:  R D Daimond; R Krzesicki
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

8.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.

Authors:  R D Diamond; R Krzesicki; W Jao
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures.

Authors:  R Y Tsien
Journal:  Biochemistry       Date:  1980-05-27       Impact factor: 3.162

10.  The anticomplementary effect of kidney tissue; its association with ammonia production.

Authors:  P B BEESON; D ROWLEY
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

View more
  4 in total

1.  Deletion of the SSK1 response regulator gene in Candida albicans contributes to enhanced killing by human polymorphonuclear neutrophils.

Authors:  Chen Du; Richard Calderone; John Richert; Dongmei Li
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.

Authors:  T Vago; G Baldi; D Colombo; M Barbareschi; G Norbiato; F Dallegri; M Bevilacqua
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

3.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

4.  Candida albicans response regulator gene SSK1 regulates a subset of genes whose functions are associated with cell wall biosynthesis and adaptation to oxidative stress.

Authors:  Neeraj Chauhan; Diane Inglis; Elvira Roman; Jesus Pla; Dongmei Li; Jose A Calera; Richard Calderone
Journal:  Eukaryot Cell       Date:  2003-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.